Viking Therapeutics (VKTX)
Develops clinical-stage therapies for obesity, metabolic and endocrine disorders.
$39.83
vs last close+9.72 (+32.28%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 65.57% | 76.48M shares | |
|---|---|---|---|
| 471 holders · as of Jun 30, 2026 | |||
| Insiders | 2.96% | 3.45M shares | |
| 10 holders · as of Aug 7, 2026 | |||
| Other | 31.47% | 36.71M shares | |
| remainder | |||
116.65M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
471 holders · 76.48M shares · 75 new positions · 222 increased · 134 reduced · 54 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 6.34M | 5.43% | +311.0K | Aug 13, 2026 |
| BlackRock, Inc. | 6.19M | 5.31% | −690.6K | Aug 7, 2026 |
| State Street Corp | 5.61M | 4.81% | +1.21M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 5.05M | 4.33% | +41.2K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 4.48M | 3.84% | +20.0K | Aug 13, 2026 |
| Two Sigma Investments, LP | 3.94M | 3.38% | −494.7K | Aug 14, 2026 |
| Morgan Stanley | 3.49M | 2.99% | +472.1K | Aug 13, 2026 |
| Ameriprise Financial Inc | 2.16M | 1.85% | +477.3K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 5.10% | 5.77M | 13G | Nov 5, 2025 |
| Vanguard Capital Management | 5.08% | 5.88M | 13G | Apr 30, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 29, 2026 | Marianna Manciniofficer: Chief Operating Officer | Sale | 18,217 | $33.47 | 422,760 |
| Jul 29, 2026 | Greg Zanteofficer: Chief Financial Officer | Sale | 21,217 | $33.47 | 212,204 |
| Jul 29, 2026 | Brian Liandirector, officer: President & CEO | Sale | 148,517 | $33.32 | 2,572,441 |
| Mar 10, 2026 | Neil William Aubuchonofficer: Chief Commercial Officer | Purchase | 4,475 | $33.50 | 4,475 |
| Jan 2, 2026 | Matthew W. Foehrdirector | Sale | 16,000 | $35.11 | 132,036 |
| Jan 5, 2026 | Brian Liandirector, officer: President & CEO | Sale · 4 lots | 233,409 | $32.96 | 2,499,291 |
| Jan 5, 2026 | Marianna Manciniofficer: Chief Operating Officer | Sale · 4 lots | 57,661 | $32.98 | 409,190 |
| Jan 5, 2026 | Greg Zanteofficer: Chief Financial Officer | Sale · 4 lots | 57,661 | $32.90 | 189,891 |
| Oct 28, 2025 | Greg Zanteofficer: Chief Financial Officer | Sale | 6,185 | $35.00 | 173,592 |
| Oct 28, 2025 | Brian Liandirector, officer: President & CEO | Sale | 38,989 | $35.01 | 2,419,109 |
House and Senate disclosures
Not reported.